13G Filing: Brookside Capital and Immune Design Corp. (IMDZ)

Page 7 of 7

Page 7 of 7 – SEC Filing

The percentage of Common Stock reported owned by the Reporting Persons
is based upon 25,619,732 shares of Common Stock outstanding as reported
in the Issuer’s Quarterly Report on Form 10-Q dated June 30, 2017.
The percentage of Common Stock reported owned by the Reporting Persons
is based upon 25,619,732 shares of Common Stock outstanding as reported
in the Issuer’s Quarterly Report on Form 10-Q dated June 30, 2017. The
percentage of Common Stock reported owned by the Reporting Persons is
based upon 25,619,732 shares of Common Stock outstanding as reported
in the Issuer’s Quarterly Report on Form 10-Q dated June 30, 2017.48220740_1
48220740_1
48220740_1
48220740_1

Follow Immune Design Corp. (NASDAQ:IMDZ)

Page 7 of 7